Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. (DRUG) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
drug · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$220
Consensus
$160
+144.3% upside
Low
$126
Median: $146 · Last Close: $65.28
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$159.50
144.3% upside
High Target
$220
237.0%
Low Target
$126
93.0%
Current Price
$65.28
as of today
Based on analyst price targets, the DRUG stock price prediction for the next 12 months ranges from $126 to $220. The consensus DRUG price forecast of $159.50 implies 144.3% upside from the current price of $65.28.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $62.02 | ↓ 5.00% |
1-day model range: $61.56–$62.47. Peak: $62.47 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $62 | -4.6% |
| 2028 | $61 | -7.0% |
| 2029 | $60 | -8.3% |
| 2030 | $59 | -9.0% |
| 2031 | — | -9.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DRUG · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-20 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-30 | BTIG | Maintains | Buy→Buy |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-17 | BTIG | Maintains | Buy→Buy |
| 2026-01-07 | BTIG | Maintains | Buy→Buy |
| 2026-01-06 | BTIG | Maintains | Buy→Buy |
| 2026-01-02 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bright Minds Biosciences Inc. (DRUG) stock. Of the recent 13 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover DRUG.
Analyst Recommendation Trends
DRUG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$34M
EPS This Year
$-6.52
EPS Next Year
$-12.84
↑ 97.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast DRUG EPS of $-6.52 for the current fiscal year, based on estimates from 5 analysts. The DRUG revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DRUG stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DRUG price target is $159.50 (+144.3% upside), with an analyst consensus of Buy.
The DRUG short-term stock prediction for tomorrow is $62.02 (-5.00%). The DRUG stock price prediction for 2027 estimates an average of $62. The DRUG stock prediction for 2030 projects a range of $55–$64.
Bright Minds Biosciences Inc. trades on NASDAQ under the ticker DRUG. The DRUG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
DRUG forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month DRUG price target is $159.50, with a high forecast of $220.00 and a low of $126.00. The median price target is shown in the chart above when available. This implies +144.3% potential upside from the current price of $65.28.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.